CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes

Diabetologia
Bruce BuckinghamDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups

Abstract

The aim of this work was to assess the association between continuous glucose monitoring (CGM) data, HbA1c, insulin-dose-adjusted HbA1c (IDAA1c) and C-peptide responses during the first 2 years following diagnosis of type 1 diabetes. A secondary analysis was conducted of data collected from a randomised trial assessing the effect of intensive management initiated within 1 week of diagnosis of type 1 diabetes, in which mixed-meal tolerance tests were performed at baseline and at eight additional time points through 24 months. CGM data were collected at each visit. Among 67 study participants (mean age [± SD] 13.3 ± 5.7 years), HbA1c was inversely correlated with C-peptide at each time point (p < 0.001), as were changes in each measure between time points (p < 0.001). However, C-peptide at one visit did not predict the change in HbA1c at the next visit and vice versa. Higher C-peptide levels correlated with increased proportion of CGM glucose values between 3.9 and 7.8 mmol/l and lower CV (p = 0.001 and p = 0.02, respectively) but not with CGM glucose levels <3.9 mmol/l. Virtually all participants with IDAA1c < 9 retained substantial insulin secretion but when evaluated together with CGM, time in the range of 3.9-7.8 mmol/l and C...Continue Reading

References

Jan 1, 1991·Diabetes Research and Clinical Practice·J J CouperL C Harrison
Jan 29, 2005·Diabetes Care·Edmond A RyanA M James Shapiro
Jun 28, 2006·Diabetes Technology & Therapeutics·UNKNOWN Diabetes Research In Children Network (Direcnet) Study GroupWilliam V Tamborlane
May 14, 2009·Diabetes Care·Henrik B MortensenUNKNOWN Hvidoere Study Group on Childhood Diabetes
Feb 20, 2010·Journal of Diabetes Science and Technology·Jessica R Castle, W Kenneth Ward
Dec 14, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·W K WardJ R Castle
Feb 11, 2012·Diabetes Care·Jennifer SherrUNKNOWN Diabetes Research in Children Network (DirecNet) Study Group
Jan 10, 2013·Diabetes Technology & Therapeutics·Roy W BeckCraig Kollman
Oct 17, 2013·Diabetes Care·Bruce BuckinghamUNKNOWN Type 1 Diabetes TrialNet Study Group

❮ Previous
Next ❯

Citations

May 16, 2015·Diabetes Technology & Therapeutics·Eric Renard
Apr 1, 1997·The American Journal of Medicine·R C DetranoR Shavelle
Jul 9, 2016·Expert Review of Molecular Diagnostics·Johnny Ludvigsson
Jan 28, 2020·Diabetes, Obesity & Metabolism·Vit NeumanZdenek Sumnik
Oct 18, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·D TatovicUNKNOWN MonoPepT1De Study Group
Aug 2, 2020·International Journal of Epidemiology·Louise A C MillardDebbie A Lawlor
Feb 3, 2021·The Journal of Clinical Investigation·Anna LamKevan C Herold
Aug 15, 2021·The Journal of Clinical Endocrinology and Metabolism·Yan ChenZhiguang Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.